Continuous monitoring of protein damaging toxicity using a recombinant bioluminescent Escherichia coli

Man Bock Gu, Robert J. Mitchell, Joong Hyun Kim

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Through the use of the recombinant bacterium TV 1061, containing a grpE-luxCDABE fusion, and a previously developed continuous toxicity monitoring system we were able to detect protein damaging toxicity in aqueous systems. This bacterial strain is responsive to the toxicity of protein-damaging agents and produces a bioluminescent response in their presence. The system uses the two-stage mini-bioreactors previously developed in our lab which allows stability even under the conditions that the toxicity greatly exceeded the sub-lethal level. The response of the strain under these conditions shows a unique signature when compared to previously tested strains.

Original languageEnglish
Pages (from-to)185-196
Number of pages12
JournalACS Symposium Series
Volume762
Publication statusPublished - 2000 Dec 1
Externally publishedYes

Fingerprint

Escherichia coli
Toxicity
Proteins
Monitoring
Bioreactors
Bacteria
Fusion reactions

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Continuous monitoring of protein damaging toxicity using a recombinant bioluminescent Escherichia coli. / Gu, Man Bock; Mitchell, Robert J.; Kim, Joong Hyun.

In: ACS Symposium Series, Vol. 762, 01.12.2000, p. 185-196.

Research output: Contribution to journalArticle

@article{6451ef2dce7e4c6d96d9a68365ec4cfa,
title = "Continuous monitoring of protein damaging toxicity using a recombinant bioluminescent Escherichia coli",
abstract = "Through the use of the recombinant bacterium TV 1061, containing a grpE-luxCDABE fusion, and a previously developed continuous toxicity monitoring system we were able to detect protein damaging toxicity in aqueous systems. This bacterial strain is responsive to the toxicity of protein-damaging agents and produces a bioluminescent response in their presence. The system uses the two-stage mini-bioreactors previously developed in our lab which allows stability even under the conditions that the toxicity greatly exceeded the sub-lethal level. The response of the strain under these conditions shows a unique signature when compared to previously tested strains.",
author = "Gu, {Man Bock} and Mitchell, {Robert J.} and Kim, {Joong Hyun}",
year = "2000",
month = "12",
day = "1",
language = "English",
volume = "762",
pages = "185--196",
journal = "ACS Symposium Series",
issn = "0097-6156",
publisher = "American Chemical Society",

}

TY - JOUR

T1 - Continuous monitoring of protein damaging toxicity using a recombinant bioluminescent Escherichia coli

AU - Gu, Man Bock

AU - Mitchell, Robert J.

AU - Kim, Joong Hyun

PY - 2000/12/1

Y1 - 2000/12/1

N2 - Through the use of the recombinant bacterium TV 1061, containing a grpE-luxCDABE fusion, and a previously developed continuous toxicity monitoring system we were able to detect protein damaging toxicity in aqueous systems. This bacterial strain is responsive to the toxicity of protein-damaging agents and produces a bioluminescent response in their presence. The system uses the two-stage mini-bioreactors previously developed in our lab which allows stability even under the conditions that the toxicity greatly exceeded the sub-lethal level. The response of the strain under these conditions shows a unique signature when compared to previously tested strains.

AB - Through the use of the recombinant bacterium TV 1061, containing a grpE-luxCDABE fusion, and a previously developed continuous toxicity monitoring system we were able to detect protein damaging toxicity in aqueous systems. This bacterial strain is responsive to the toxicity of protein-damaging agents and produces a bioluminescent response in their presence. The system uses the two-stage mini-bioreactors previously developed in our lab which allows stability even under the conditions that the toxicity greatly exceeded the sub-lethal level. The response of the strain under these conditions shows a unique signature when compared to previously tested strains.

UR - http://www.scopus.com/inward/record.url?scp=0039845514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0039845514&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0039845514

VL - 762

SP - 185

EP - 196

JO - ACS Symposium Series

JF - ACS Symposium Series

SN - 0097-6156

ER -